These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1007759)

  • 1. Prostaglandins and prostaglandin precursors as endogenous antiarrhythmic principles of the heart.
    Förster W
    Acta Biol Med Ger; 1976; 35(8-9):1101-112. PubMed ID: 1007759
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiarrhythmic effects of prostaglandin E1, A1 and F2beta against CaCl2- and aconitin-arrhythmias in the rat].
    Mentz P; Förster W
    Acta Biol Med Ger; 1974; 33(2):245-8. PubMed ID: 4463641
    [No Abstract]   [Full Text] [Related]  

  • 3. [The anti-arrhythmic effect of prostaglandins A1, E1, A2, E2 and F2a in the cat strophanthin arrhythmia model].
    Mest HJ; Blass KE; Förster W
    Acta Biol Med Ger; 1976; 35(1):63-7. PubMed ID: 983602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmic effects of prostaglandins F2alpha, E2, and A2 on CaCl2-and aconitine-arrhythmias].
    Mentz P; Förster W
    Acta Biol Med Ger; 1974; 32(4):393-402. PubMed ID: 4408576
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal models of cardiac arrhythmias.
    Janse MJ; Opthof T; Kléber AG
    Cardiovasc Res; 1998 Jul; 39(1):165-77. PubMed ID: 9764198
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of a combination of N-propylajmaline bromide and trimecaine on heart arrhythmias of different origins and on the electrophysiological parameters of the myocardium].
    Gendenshteĭn EI; Balashov VP; Sosunov EA; Kostin IaV; Oleĭnikov VE
    Farmakol Toksikol; 1991; 54(4):30-3. PubMed ID: 1786818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiostimulating and antiarrhythmic effect of secretin].
    Schölkens B
    Verh Dtsch Ges Kreislaufforsch; 1971; 37():294-8. PubMed ID: 5003861
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostaglandins and the heart].
    Pomoĭnetskiĭ VD
    Ter Arkh; 1980; 52(6):141-6. PubMed ID: 6250242
    [No Abstract]   [Full Text] [Related]  

  • 11. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antiarrhythmic action of the synthetic acetylcholine analog EDIHYP in calcium chloride- and strophanthin-induced heart rhythm disorders].
    Abdikaliev NA; Kalvin'sh IIa; Meerson FZ
    Farmakol Toksikol; 1991; 54(6):25-8. PubMed ID: 1804687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of PGF2 alpha on experimental arrhythmias.
    Förster W; Mest HJ; Mentz P
    Prostaglandins; 1973 Jun; 3(6):895-904. PubMed ID: 4729607
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 15. [The anti-arrhythmic activity of the arylamides of alpha-hexamethyleneiminocarboxylic acids].
    Berdiaev SIu; Turilova AI; Lebedeva AS; Likhosherstov AM; Ninidze IG; Kaverina NV; Skoldinov AP
    Farmakol Toksikol; 1991; 54(3):32-4. PubMed ID: 1915816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological study of quaternary trimecaine derivatives].
    Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP; Bukauskas FF
    Farmakol Toksikol; 1983; 46(4):36-40. PubMed ID: 6617835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis.
    Konturek SJ; Radecki T; Brzozowski T; Piastucki I; Dembiński A; Dembińska-Kieć A; Zmuda A; Gryglewski R; Gregory H
    Gastroenterology; 1981 Sep; 81(3):438-43. PubMed ID: 7018988
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic properties of Craviten (M-71) in cats and rabbits.
    Chodera A; Banaszkiewicz W; Glinka B
    Pol J Pharmacol Pharm; 1980; 32(6):833-40. PubMed ID: 7243680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological research on bonnecor and its metabolites].
    Poppe H; Heer S; Barch R
    Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.